RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Clinical trial NCT04105270 · RECRUITING
Trial details
- NCT number
- NCT04105270
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2028-01-01
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.